Article info
PDFLetter
Weight loss induced by orlistat reverses fatty infiltration and improves hepatic fibrosis in obese patients with non-alcoholic steatohepatitis
- Correspondence to:
Dr N Assy
Liver Unit, Sieff Government Hospital, POB 1008, Safed 13100, Israel; assy.n{at}ziv.health.gov.il
Citation
Weight loss induced by orlistat reverses fatty infiltration and improves hepatic fibrosis in obese patients with non-alcoholic steatohepatitis
Publication history
- First published March 5, 2007.
Online issue publication
April 18, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2007 by Gut